News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tillotts Pharma AG and MediSafe Partner to Go Beyond the Tablet With UCandME™ Program



10/17/2013 10:01:58 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RHEINFELDEN, Switzerland, Oct. 17, 2013 (GLOBE NEWSWIRE) -- Tillotts Pharma AG ("Tillotts"), a Swiss pharmaceutical company specializing in the development and commercialization of pharmaceutical products, diagnostics, and medical devices in the field of gastroenterology, and MediSafe, a global, award-winning mobile medication management solution, announced today the first virtual tablet box created specifically for patients suffering from Ulcerative Colitis ("UC"). Sponsored and led by Tillotts, and powered by MediSafe, the UCandMETM program strives to go beyond simply taking medication by bringing solutions to health care professionals and patients suffering from UC.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES